A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

Mario Sabatelli, D Cocito, I Paolasso, G Antonini, L Benedetti, C Briani, C Comi, R Fazio, S Jann, S Matà, A Mazzeo, E. Nobile Orazio

Risultato della ricerca: Contributo in rivistaArticolo in rivista

85 Citazioni (Scopus)

Abstract

The guidelines for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) therapy suggest to use immunoglobulins (IVIg) and steroid as first-line therapies. Patients who do not respond to one of the two drugs should be switched to the other drug. We collected therapeutic outcome data in patients followed at 11 centres in order to document the clinical practice in Italy.
Lingua originaleEnglish
pagine (da-a)289-294
Numero di pagine6
RivistaEUROPEAN JOURNAL OF NEUROLOGY
Volume17
DOI
Stato di pubblicazionePubblicato - 2010

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Databases, Factual
  • Humans
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Immunotherapy
  • Italy
  • Middle Aged
  • Plasma Exchange
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Registries
  • Retrospective Studies
  • Steroids
  • Treatment Outcome
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy'. Insieme formano una fingerprint unica.

Cita questo